Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BIOAF

biOasis Technologies Inc is a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier and into the brain tissue. Its focus is to address unmet medical needs with its proprietary Transcend Platform.
Price: $1.10 | Change: $0.00 | %Change: 0.00%
Volume: 17,100 | Day High/Low: 1.10/1.06 | 52 Week High/Low: 1.50/0.75
View modes: 
1 star

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

To nitpick: These are Technology Access Agreements, not Transfer agreements. Big difference!  rate and reply
2 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

I dont understand how the market can understand "TTA" styles of aggreements in regards to every other company that is or has been involved with them. but in regards to bioasis we continue to get more
4 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

These Technology Transfer Agreements (TTAs) are often two-stage with safety and pharmacokinetics being the first stage and efficacy the second, with each stage providing revenue. The agreements, as more
1 star

RE:RE:RE:RE:RE:RE:RE:RE:Quarterly Report

I am not so sure about being all CF positive...TAA unless it's a recurring payments, I thought these are one time paymen type of deal?  rate and reply
4 stars

RE:RE:RE:RE:RE:RE:RE:Quarterly Report

Yup, that's what it means, MineDigger, and why I say that unless biOasis has the need for a lot of money for a specific purpose like a costly study or trial, then we may have seen the last of more
3.5 stars

RE:RE:RE:RE:RE:RE:Quarterly Report

jd, About the cash burn and having now listened to the BWH video... Rob actually says, re TAAs, "we're actually seeing now revenue starting to flow from those agreements and that's covering more
3.5 stars

When will results be announced

Love the potential. Stock price has been weak lately. Surprised it didn't get more of a bounce on the recent harvard news. I don't think many people know about this exciting company. more
0 stars


You can search 'The Transcend Repot' at YouTube for the new video and archive.  rate and reply
0 stars


Where can I access this video...the BTI WEBSITE?  rate and reply
3.5 stars

RE:today's topic

What substantive thing would you like to talk about today, drjekyl? Your "answers" to my deal questions certainly were not substantive. They were fluff. What big topic would you like to offer us more
2.5 stars

today's topic

surely I can't be the only one who would rather be talking about something more substantive than a low budget video about an antiquated press release. maybe I'm missing something. on second more
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:Video  rate and reply
4 stars


It is Harvard, Sir_Holler, as if Harvard needs promoting. BWH is where Harvard does such work. You know, hospital, clinic, clinical trials, patients, doctors, research, all those things that more
3 stars


Sir_Holler wanted to make a big deal out of me providing (or not providing) information about Dr. Sean Lawler of Harvard Medical School. He wanted to know why I made a big deal of Scarpa but not more
2.5 stars


Ok jd. Go on and keep promoting Harvard.  rate and reply
4 stars


Tell you what, Sir_Holler, you go get his credentials. Instead of me and a couplle of others doing everything, you do it, just once, ok? Wouldn't suit your purpose, though, would it? You like more
2.5 stars


You don't seem to be able to list the drugs he's behind developing for brain cancer, or the major breakthroughs, and I don't see any specific mention of his influence in the field. He's the more
5 stars


Sir_Holler, do you really think that Dr. Sean Lawler can enlist Brigham & Women's Hospital's resources on some dort of personal whim? Do you have any idea how precious the resources of Harvard more
1.5 stars

RE:RE:RE:RE:RE:Quarterly Report

jd, nice to hear that a raise is unlikely, and although you rightly point out that the MD&As all have various risk warnings, the point about BTI's is that we have arrived at the cusp of their more
2.5 stars


SHould have said Lawler.  rate and reply